Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1341 results for "pharma"

Marksans Pharma gets USFDA clearance for allergy drug
Financial Express

Marksans Pharma spurts 14% in two sessions

Marksans Pharma rose 2.92% to Rs 54.55 at 13:44 IST on BSE, extending yesterday's 10.76% triggered by the company receiving USFDA approval for an ANDA for Loratadine liquid filled capsules 10 mg. Meanwhile, the BSE Sensex was up 26.13 points, or ... Capital Market, 7 hours ago
[x]  

6,838 images for pharma

WKRB News, 10 hours ago
WKRB News, 2 hours ago
Mideast Time, 1 day ago
American Banking News, 14 hours ago
Business Today India, 1 day ago
Minyanville, 4 hours ago
Yahoo! Singapore, 4 hours ago
Mideast Time, 1 day ago
Financial Buzz, 21 hours ago
BioSpace, 21 hours ago
Money Control

Buy Ajanta Pharma, target Rs 2275: Dharmesh Shah

Dharmesh Shah of ICICI Direct has Buy call on Ajanta Pharma Ltd. with a target price of Rs 2275.0. The current market price of Ajanta Pharma Ltd. is 2080.15. Time period given by analyst is 1-3 Days, when Ajanta Pharma Ltd. price can reach defined ...
 Economic Times8 hours ago Buy Ajanta Pharma Ltd., target Rs 2275.0 : Dharmesh Shah  Economic Times9 hours ago Outperform Aurobindo Pharma., target Rs 910: Credit Suisse  Economic Times1 day ago Cut target on GSK Pharma, see gradual recovery: Credit Suisse  Money Control1 day ago
DNA

Pfizer completes sale of 4 products to Piramal Enterprises

In May 2016, the US-based pharma major entered into an agreement with Piramal Enterprises to sell its four products for a total consideration of Rs 110 crores BS B2B Bureau | Mumbai September 27, 2016 Last Updated at 14:35 IST Pfizer Ltd has concluded the ...
 Business Standard6 hours ago Pfizer shares down nearly 2% on sale of 4 products  DNA8 hours ago

Stay invested in Marksans Pharma, says Rajat Bose

Rajat Bose of rajatkbose.com is of the view that one may stay invested in Marksans Pharma.
 Money Control5 hours ago Prefer Aurobindo Pharma, Dr Reddy's Lab, Biocon: Rajat Bose  Money Control5 days ago Sell Yes Bank, hold Aurobindo Pharma: Rajat Bose  Money Control5 days ago Buy Aurobindo Pharma, HDFC: Rajat Bose  Money Control5 days ago

Don't expect big returns from large-cap pharma: Surajit Pal

Don't expect big returns from large-cap pharma: Surajit Pal - Moneycontrol.com By Expressing concern that drug majors are running out of cash in the US market and their generics business is shrinking, Surajit Pal of Prabhudas Lilladher said he ...
 Moneycontrol.com4 hours ago Don’t expect big returns from large-cap pharma: Surajit Pal  Money Control4 hours ago

Buy Aurobindo Pharma; sell ICICI Bank: Ashwani Gujral

Like this story, share it with millions of investors on M3 According to Ashwani Gujral of ashwanigujral.com, one may buy Aurobindo Pharma and advises selling ICICI Bank and
 Moneycontrol.com10 hours ago Sell Lupin, buy Ajanta Pharma: Mitesh Thacker  Money Control4 days ago Buy Marksans Pharma, IRB Infra; sell HUL, Hexaware: Thacker  Money Control6 days ago Buy Ajanta Pharma, IOC, United Breweries: Mitesh Thacker  Money Control1 week ago

Sell Bharti Airtel; buy HPCL, Ajanta Pharma: Rajat K Bose

Rajat K Bose of rajatkbose.com is of the view that one may sell Bharti Airtel and advises buying Ajanta Pharma.
 Money Control10 hours ago Buy Bata India, Sun Pharma; sell Exide Industries: Rajat Bose  Money Control2 weeks ago

Positive on Marksans Pharma, says Sharmila Joshi

Sharmila Joshi of sharmilajoshi.com is positive on Marksans Pharma.
 Money Control6 hours ago

Sensex, Nifty sluggish; IT pharma stocks rise, infra down

Asian Paints, TCS, Infosys, Lupin and Wipro are top gainers while Bharti Airtel, ONGC, LT, Adani Ports and BHELare losers in the Sensex.
 Money Control8 hours ago Nifty continues to struggle below 8750, LT, ICICI, Bharti drag  Money Control10 hours ago
Freshnews.com

BRIEF-Athenex, Sungen Pharma enter JV for pharmaceuticals portfolio

CORRECTED-Just 30 doctors struggle to treat wounded in eastern Aleppo GENEVA, Sept 26 Only 30 doctors remain in rebel-held eastern Aleppo, where they are in dire need of medical and surgical supplies to treat hundreds of wounded people among a ...
 Reuters UK21 hours ago Athenex and SunGen Pharma to Market a Portfolio of Seven Approved Pharmaceutical Products  American Pharmaceutical Review16 hours ago Athenex Inc. and SunGen Pharma enter into U.S. joint venture agreement for a portfolio of 7 approved pharmaceutical products  BioSpace21 hours ago Athenex Inc and SunGen Pharma enter into US joint venture agreement for a portfolio of 7 approved pharmaceutical products  Pharma Focus Asia11 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less